Weiss, Brandon http://orcid.org/0000-0003-2989-2981
Roseman, Leor
Giribaldi, Bruna
Nutt, David J.
Carhart-Harris, Robin L.
Erritzoe, David
Article History
Accepted: 1 February 2024
First Online: 7 March 2024
Declarations
:
: The original clinical trial was approved by the Brent Research Ethics Committee, the U.K. Medicines and Healthcare Products Regulatory Agency, the Health Research Authority, the Imperial College London Joint Research Compliance and General Data Protection Regulation Offices, and the risk assessment and trial management review board at the trial site (the National Institute for Health Research Imperial Clinical Research Facility).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
: L. R. and B. G. declare no competing interests.B. W. owns Axial Therapeutic Research, Inc., a company investigating the safety and effectiveness of alternative treatments for military veteran health.D. N. reports being Chief Research Officer at Awakn Life Sciences, and receives consulting fees from Psyched Wellness, Neural Therapeutics, and Alvarius.D. E. reports receiving consulting fees from Aya, Mindstate Design Lab, Clerkenwell Health.R. C.-H. reports receiving consulting fees from TRYP Therapeutics, Journey Collab, Osmind, Mindstate Design Lab, Entheos Labs, and Otsuka.